Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MBXMBX Biosciences, Inc.

Nasdaq · CIK 0001776111
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts172

Identity from submissions API

NameMBX Biosciences, Inc.
CIK0001776111
TickersMBX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone3179893100
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
11711 N. MERIDIAN STREET
SUITE 300
CARMEL
IN
46032
IN
Mailing address
11711 N. MERIDIAN STREET
SUITE 300
CARMEL
IN
46032
IN

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

238 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128295 005-94623 261560850 34 12458
2026-11-12 4 4 0001193125-26-457015 6564
2026-11-10 144 xsl144X01/primary_doc.xml 0001959173-26-007930 001-42272 261542101 33 4496
2026-11-10 S-8 S-8 0001193125-26-453959 333-299939 261537284 33 408938 1 1
2026-11-09 10-Q 10-Q 0001193125-26-453583 001-42272 261535976 34 10934882 1 1
2026-11-09 8-K 8-K 2.02,7.01,9.01 0001193125-26-453553 001-42272 261535862 34 12307500 1 1
2026-11-05 4 4 0001193125-26-449832 5480
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002806 005-94623 261526260 34 11794
2026-11-04 144 xsl144X01/primary_doc.xml 0001959173-26-007744 001-42272 261521659 33 5133
2026-10-22 4 4 0001193125-26-428390 5516
2026-10-22 3 3 0001193125-26-428386 14692
2026-10-22 8-K 8-K 5.02,9.01 0001193125-26-428367 001-42272 261477264 34 160327 1 1
2026-08-27 8-K 8-K 7.01,8.01,9.01 0001193125-26-369674 001-42272 261325318 34 235945 1 1
2026-08-17 144 xsl144X01/primary_doc.xml 0001959173-26-006112 001-42272 261286525 33 5122
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003482 005-94623 261276375 34 11486
2026-08-10 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001231919-26-000851 005-94623 261259787 34 36601
2026-08-10 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000947871-26-000776 005-94623 261259146 34 30282
2026-08-06 10-Q 10-Q 0001193125-26-336849 001-42272 261246149 34 8773231 1 1
2026-08-06 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-26-336841 001-42272 261246131 34 12077146 1 1
2026-08-05 4 4 0001193125-26-335373 16719
2026-08-04 144 xsl144X01/primary_doc.xml 0001959173-26-005629 001-42272 261239609 33 5173
2026-08-04 144 xsl144X01/primary_doc.xml 0001959173-26-005628 001-42272 261239568 33 5767
2026-08-04 4 4 0001193125-26-331642 18681
2026-08-04 4 4 0001193125-26-331639 19829
2026-07-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002818 005-94623 261216880 34 10912
2026-07-13 8-K 8-K 5.02 0001193125-26-302098 001-42272 261171814 34 155091 1 1
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902219-26-000214 005-94623 261161699 34 17308
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001474 005-94623 261161021 34 11335
2026-06-24 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-077301 005-94623 261115902 34 17204
2026-06-12 8-K 8-K 7.01,8.01,9.01 0001193125-26-268477 001-42272 261084898 34 15816244 1 1
2026-06-10 144 xsl144X01/primary_doc.xml 0001959173-26-004511 001-42272 261078944 33 9927
2026-06-09 144 xsl144X01/primary_doc.xml 0001959173-26-004487 001-42272 261076634 33 9326
2026-06-05 4 4 0001193125-26-259236 5355
2026-06-05 4 4 0001193125-26-258436 6051
2026-06-05 4 4 0001193125-26-258435 5439
2026-06-05 4 4 0001193125-26-258432 5460
2026-06-05 4 4 0001193125-26-258429 7167
2026-06-05 4 4 0001193125-26-258422 5435
2026-06-05 4 4 0001193125-26-258420 5474
2026-06-05 8-K 8-K 5.02,5.07 0001193125-26-258417 001-42272 261066879 34 172450 1 1
2026-05-13 144 xsl144X01/primary_doc.xml 0001959173-26-003576 001-42272 26973548 33 8682
2026-05-11 4 4 0001193125-26-216704 14825
2026-05-11 144 xsl144X01/primary_doc.xml 0001959173-26-003490 001-42272 26962821 33 9642
2026-05-11 8-K 8-K 7.01,8.01,9.01 0001193125-26-215676 001-42272 26960831 34 15647085 1 1
2026-05-08 144 xsl144X01/primary_doc.xml 0001959173-26-003434 001-42272 26958413 33 5622
2026-05-08 DEFA14A DEFA14A 0001193125-26-214615 001-42272 26958254 34 88730
2026-05-08 4 4 0001193125-26-214582 5498
2026-05-08 4 4 0001193125-26-214574 6585
2026-05-08 144 xsl144X01/primary_doc.xml 0001959173-26-003419 001-42272 26957088 33 8467
2026-05-07 144 xsl144X01/primary_doc.xml 0001959173-26-003370 001-42272 26952069 33 7298
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-210825 001-42272 26951518 34 292998 1 1
2026-05-07 10-Q 10-Q 0001193125-26-210593 001-42272 26951164 34 7926583 1 1
2026-05-06 144 xsl144X01/primary_doc.xml 0001959173-26-003340 001-42272 26947975 33 4540
2026-05-06 144 xsl144X01/primary_doc.xml 0001959173-26-003333 001-42272 26947875 33 4491
2026-05-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001256 005-94623 26946867 34 11146
2026-05-04 4 4 0001193125-26-202615 8202
2026-05-01 144 xsl144X01/primary_doc.xml 0001959173-26-003192 001-42272 26931791 33 6806
2026-04-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001704 005-94623 26901055 34 10924
2026-04-22 144 xsl144X01/primary_doc.xml 0001959173-26-003033 001-42272 26882272 33 6625
2026-04-22 ARS ARS 0001193125-26-168545 001-42272 26881339 34 12045920
2026-04-22 DEFA14A DEFA14A 0001193125-26-168543 001-42272 26881335 34 1191033
2026-04-22 DEF 14A DEF 14A 0001193125-26-168536 001-42272 26881329 34 3970561 1 1
2026-04-22 4/A 4/A 0001193125-26-168530 5904
2026-04-22 4/A 4/A 0001193125-26-168524 5833
2026-03-25 144 xsl144X01/primary_doc.xml 0001959173-26-002613 001-42272 26791777 33 5144
2026-03-18 3 3 0001193125-26-113899 14583
2026-03-16 144 xsl144X01/primary_doc.xml 0001959173-26-002351 001-42272 26756033 33 4898
2026-03-16 4 4 0001193125-26-107268 6093
2026-03-12 S-3ASR S-3ASR 0001193125-26-104097 333-294237 26747678 33 2029304 1 1
2026-03-12 S-8 S-8 0001193125-26-103122 333-294228 26745726 33 326821 1 1
2026-03-12 10-K 10-K 0001193125-26-103121 001-42272 26745720 34 16466203 1 1
2026-03-12 8-K 8-K 2.02,9.01 0001193125-26-103118 001-42272 26745705 34 324861 1 1
2026-03-09 8-K 8-K 7.01,8.01,9.01 0001193125-26-097611 001-42272 26733254 34 205087 1 1
2026-02-27 4 4 0001193125-26-082562 7916
2026-02-27 8-K 8-K 1.01,5.02,9.01 0001193125-26-079286 001-42272 26692675 34 2564351 1 1
2026-02-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-26-000114 005-94623 26622557 34 31134
2026-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-26-000071 005-94623 26614306 34 17189
2026-02-05 8-K 8-K 8.01 0001193125-26-039475 001-42272 26603312 34 154879 1 1
2026-02-03 4 4 0001193125-26-035587 7043
2026-02-03 4 4 0001193125-26-035584 7031
2026-02-03 4 4 0001193125-26-035582 8153
2026-01-22 4 4 0001193125-26-018702 5389
2026-01-22 3 3 0001193125-26-018701 14428
2026-01-22 8-K 8-K 5.02,7.01,9.01 0001193125-26-018700 001-42272 26549717 34 237251 1 1
2026-01-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000690 005-94623 26545863 34 10783
2026-01-12 144 xsl144X01/primary_doc.xml 0001959173-26-000259 001-42272 26526593 33 5429
2026-01-12 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-26-009642 001-42272 26524524 34 263000 1 1
2025-12-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003581 333-291308 251557515 33 1754
2025-12-04 CORRESP filename1.htm 0001193125-25-308171 20752
2025-11-25 4 4 0001193125-25-294675 5227
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-282917 005-94623 251485860 34 7842
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001903360-25-000005 005-94623 251474770 34 6766
2025-11-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001072613-25-000781 005-94623 251467319 34 78221
2025-11-07 4 4 0001193125-25-271118 5292
2025-11-06 S-3 S-3 0001193125-25-268202 333-291308 251456390 33 4717333 1 1
2025-11-06 10-Q 10-Q 0001193125-25-268148 001-42272 251456285 34 8603993 1 1
2025-11-06 8-K 8-K 2.02,5.02 0001193125-25-268146 001-42272 251456281 34 378155 1 1
2025-10-28 4 4 0001193125-25-252404 8138
2025-10-21 4 4 0001193125-25-245411 6095
2025-10-20 4 4 0001193125-25-243653 5006
2025-10-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000364 005-94623 251376192 34 17205
2025-09-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000872 005-94623 251361960 34 29440
2025-09-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001876200-25-000004 005-94623 251361872 34 14830
2025-09-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001863769-25-000010 005-94623 251361320 34 50080
2025-09-30 4 xslF345X05/form4-09302025_080948.xml 0001231919-25-000267 12137
2025-09-26 8-K 8-K 1.01,9.01 0001193125-25-220432 001-42272 251350374 34 545510 1 1
2025-09-25 424B4 424B4 0001193125-25-217429 333-290447 251343714 33 1133687
2025-09-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003084 333-290447 251340143 33 1754
2025-09-24 S-1MEF S-1MEF 0001193125-25-216138 333-290498 251340027 33 329257 1 1
2025-09-22 CORRESP filename1.htm 0001193125-25-211393 29552
2025-09-22 CORRESP filename1.htm 0001193125-25-211387 20607
2025-09-22 S-1 S-1 0001193125-25-211320 333-290447 251330153 33 2042530 1 1
2025-09-22 8-K 8-K 7.01,8.01,9.01 0001193125-25-210049 001-42272 251328450 34 13576612 1 1
2025-09-04 8-K 8-K 7.01,8.01,9.01 0001776111-25-000007 001-42272 251291932 34 247488 1 1
2025-08-20 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-022503 005-94623 251237794 34 36045
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003266 005-94623 251214646 34 11326
2025-08-13 UPLOAD filename1.pdf 0000000000-25-008532 377-08307 40406
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000299 005-94623 251204911 34 17295
2025-08-08 DRS filename1.htm 0000950123-25-007329 377-08307 251196812 33 1354156
2025-08-07 10-Q 10-Q 0000950170-25-104619 001-42272 251191847 34 8144034 1 1
2025-08-07 8-K 8-K 2.02,9.01 0000950170-25-104602 001-42272 251191755 34 356037 1 1
2025-06-16 8-K 8-K 7.01,8.01,9.01 0000950170-25-086546 001-42272 251048569 34 242522 1 1
2025-06-09 8-K 8-K 7.01,9.01 0000950170-25-083447 001-42272 251032857 34 17089017 1 1
2025-06-06 4 4 0000950170-25-082773 5233
2025-06-06 4 4 0000950170-25-082713 5340
2025-06-06 4 4 0000950170-25-082703 5336
2025-06-06 4 4 0000950170-25-082702 5198
2025-06-06 4 4 0000950170-25-082701 5297
2025-06-06 4 4 0000950170-25-082699 5301
2025-06-06 4 4 0000950170-25-082698 5293
2025-06-06 8-K 8-K 5.02,5.07 0000950170-25-082697 001-42272 251028911 34 173259 1 1
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000189 005-94623 25933394 34 17282
2025-05-12 10-Q 10-Q 0000950170-25-068602 001-42272 25932713 34 7487561 1 1
2025-05-12 8-K 8-K 2.02,9.01 0000950170-25-068599 001-42272 25932703 34 336112 1 1
2025-04-23 ARS ARS 0000950170-25-056981 001-42272 25859334 34 5818296
2025-04-23 DEFA14A DEFA14A 0000950170-25-056980 001-42272 25859332 34 1198058
2025-04-23 DEF 14A DEF 14A 0000950170-25-056978 001-42272 25859330 34 3994923 1 1
2025-04-10 4 4 0000950170-25-052685 4864
2025-04-09 4 4 0000950170-25-052313 5400
2025-04-07 3 3 0000950170-25-051379 14010
2025-04-07 8-K 8-K 5.02,7.01,9.01 0000950170-25-051371 001-42272 25816429 34 239987 1 1
2025-03-17 S-8 S-8 0000950170-25-039843 333-285846 25742510 33 371852 1 1
2025-03-17 10-K 10-K 0000950170-25-039838 001-42272 25742452 34 28981983 1 1
2025-03-17 8-K 8-K 2.02,9.01 0000950170-25-039837 001-42272 25742441 34 352936 1 1
2025-02-19 4 xslF345X05/ownership.xml 0000947871-25-000200 13347
2025-02-19 4 xslF345X05/ownership.xml 0000947871-25-000199 17199
2025-02-05 4 4 0000950170-25-014499 5393
2025-02-05 4 4 0000950170-25-014497 5381
2025-02-05 4 4 0000950170-25-014494 8455
2025-01-07 8-K 8-K 2.02,7.01,8.01,9.01 0000950170-25-002555 001-42272 25513467 34 234990 1 1
2024-11-08 SC 13G SEC SCHEDULE 13G 0000902219-24-000474 005-94623 241438644 34 36172
2024-11-07 10-Q 10-Q 0000950170-24-122840 001-42272 241433359 34 8339827 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-122824 001-42272 241433300 34 299408 1 1
2024-11-01 SC 13G SC 13G 0001193125-24-249976 005-94623 241420165 34 36888
2024-09-23 SC 13D SC 13D 0001104659-24-102144 005-94623 241317230 34 150972
2024-09-23 SC 13D NEW ENTERPRISE ASSOCIATES 17, L.P. -- MBX BIOSCIENCES, INC. 13D 0001072613-24-000721 005-94623 241317226 34 469024
2024-09-23 SC 13D SCHEDULE 13D 0000947871-24-000767 005-94623 241316606 34 117463
2024-09-23 SC 13G deeptrack-mbx091324.htm 0001172661-24-004091 005-94623 241316251 34 103334
2024-09-23 SC 13D SC 13D 0001193125-24-223402 005-94623 241315132 34 417219
2024-09-20 SC 13G SEC SCHEDULE 13G 0001903360-24-000002 005-94623 241312024 34 18734
2024-09-17 4 4 0000950170-24-107558 13018
2024-09-17 4 4 0000950170-24-107556 12882
2024-09-17 4 4 0000950170-24-107554 12980
2024-09-17 4 4 0000950170-24-107552 12978
2024-09-17 4 4 0000950170-24-107549 13014
2024-09-17 4 4 0000950170-24-107547 12987
2024-09-17 4 4 0000950170-24-107544 13014
2024-09-17 4 4 0000950170-24-107542 12972
2024-09-17 4 4 0000950170-24-107540 12894
2024-09-17 4 4 0000950170-24-107538 22674
2024-09-17 4 4 0000950170-24-107537 15995
2024-09-17 4 4 0000950170-24-107536 16449
2024-09-17 4 4 0000950170-24-107532 8833
2024-09-17 4 4 0000950170-24-107530 11807
2024-09-17 4 4 0000950170-24-107527 17477
2024-09-17 4 4 0000950170-24-107525 9505
2024-09-17 4 4 0000950170-24-107524 18979
2024-09-17 4 4 0000950170-24-107489 10770
2024-09-16 8-K 8-K 5.03,9.01 0001193125-24-219621 001-42272 241301300 34 173574
2024-09-13 4 4 0000950170-24-106478 5736
2024-09-13 4 4 0000950170-24-106476 5235
2024-09-13 4 4 0000950170-24-106467 5334
2024-09-13 4 4 0000950170-24-106457 5346
2024-09-13 4 4 0000950170-24-106456 5226
2024-09-13 4 4 0000950170-24-106441 5324
2024-09-13 4 4 0000950170-24-106440 5274
2024-09-13 4 4 0000950170-24-106439 5239
2024-09-13 4 4 0000950170-24-106436 5136
2024-09-13 4 4 0000950170-24-106431 5231
2024-09-13 S-8 S-8 0001193125-24-218888 333-282106 241298092 33 98004
2024-09-13 424B5 424B5 0001193125-24-218860 333-281764 241297857 33 5001710
2024-09-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-09-12 16:00:00 9999999995-24-002818 333-281764 241296349 33 1709
2024-09-12 3 3 0000950170-24-106132 6252
2024-09-12 3 3 0000950170-24-106129 34196
2024-09-12 3 3 0000950170-24-106127 34238
2024-09-12 3 3 0000950170-24-106122 27278
2024-09-12 3 3 0000950170-24-106121 34118
2024-09-12 3 3 0000950170-24-106116 34242
2024-09-12 3 3 0000950170-24-106111 34211
2024-09-12 3 3 0000950170-24-106106 34238
2024-09-12 3 3 0000950170-24-106102 34202
2024-09-12 3 3 0000950170-24-106099 34204
2024-09-12 3 3 0000950170-24-106096 21845
2024-09-12 3 3 0000950170-24-106094 34106
2024-09-12 3 3 0000950170-24-106090 20409
2024-09-12 3 3 0000950170-24-106088 9655
2024-09-12 3 3 0000950170-24-106087 18790
2024-09-12 3 3 0000950170-24-106081 19825
2024-09-12 3 3 0000950170-24-106080 18076
2024-09-12 3 3 0000950170-24-106078 21942
2024-09-12 3 3 0000950170-24-106075 19483
2024-09-12 3 3 0000950170-24-106072 12974
2024-09-12 3 3 0000950170-24-106070 18299
2024-09-12 3 3 0000950170-24-106067 20829
2024-09-12 S-1MEF S-1MEF 0001193125-24-218157 333-282075 241295949 33 61319
2024-09-12 CERT 8A_Cert_MBX.pdf 0001354457-24-000674 001-42272 241294353 34 761632
2024-09-10 8-A12B 8-A12B 0001193125-24-216643 001-42272 241290391 34 14829
2024-09-10 CORRESP filename1.htm 0001193125-24-216604 9011
2024-09-10 CORRESP filename1.htm 0001193125-24-216599 7025
2024-09-09 S-1/A S-1/A 0001193125-24-215436 333-281764 241285721 33 5508957
2024-08-30 CORRESP filename1.htm 0001193125-24-211226 16512
2024-08-30 S-1/A S-1/A 0001193125-24-211217 333-281764 241271077 33 5873830
2024-08-30 UPLOAD filename1.pdf 0000000000-24-009916 377-07147 43496
2024-08-26 CORRESP filename1.htm 0001193125-24-207272 111789
2024-08-23 CORRESP filename1.htm 0001193125-24-206234 13333
2024-08-23 S-1 S-1 0001193125-24-206227 333-281764 241236876 33 7121724
2024-07-22 UPLOAD filename1.pdf 0000000000-24-008281 377-07147 42372
2024-07-11 DRSLTR filename1.htm 0000950123-24-006483 20332
2024-07-11 DRS/A filename1.htm 0000950123-24-006482 377-07147 241112644 33 5817493
2024-05-07 UPLOAD filename1.pdf 0000000000-24-005188 377-07147 47380
2024-04-26 DRSLTR filename1.htm 0000950123-24-003578 51109
2024-04-26 DRS/A filename1.htm 0000950123-24-003577 377-07147 24883276 33 4227439
2024-04-17 UPLOAD filename1.pdf 0000000000-24-004189 377-07147 62436
2024-03-22 DRS filename1.htm 0000950123-24-002979 377-07147 24776119 33 5281599
2022-11-18 D xslFormDX01/primary_doc.xml 06b 0001776111-22-000001 021-465364 221402325 33 12728
2020-07-27 D xslFormDX01/primary_doc.xml 06b 0001776111-20-000001 021-371833 201049071 33 7625
2019-05-10 D/A xslFormDX01/primary_doc.xml 06b 0001776111-19-000002 021-339344 19816087 33 7690
2019-05-10 D xslFormDX01/primary_doc.xml 06b 0001776111-19-000001 021-339344 19814276 33 7600

Latest XBRL company facts

One latest value per concept from companyfacts (172 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 49.66M 2026-11-05 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
dei EntityPublicFloat Entity Public Float USD 237.33M 2025-06-30 2025 FY 10-K 2026-03-12 0001193125-26-103121
ffd NetFeeAmt NetFeeAmt USD 4,257.17 2026-11-05 S-8 2026-11-10 0001193125-26-453959
ffd TtlFeeAmt TtlFeeAmt USD 4,257.17 2026-11-05 S-8 2026-11-10 0001193125-26-453959
ffd TtlOfferingAmt TtlOfferingAmt USD 48.93M 2026-11-05 S-8 2026-11-10 0001193125-26-453959
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-05 S-8 2026-11-10 0001193125-26-453959
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 6.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 5.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 17.57M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 952,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.96M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 822.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 27.55M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap Assets Assets USD 500.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AssetsCurrent Assets, Current USD 492.76M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.96M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 322.86M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 100.07M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 220.82M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 320.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 15,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 161.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 481.60M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 161.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 86.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 49.64M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 49.64M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap CommonStockValue Common Stock, Value, Issued USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -125.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 20.34M 2024-08-30 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 276,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 68.07M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 15.65M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 35.46M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 221,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 14.12M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.38M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 1.09M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 67.79M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap Depreciation Depreciation USD 283,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.259 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.027 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.086 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 64.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -69,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-039838
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 53.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -87.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 22.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -18.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 24,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 151,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -246,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 2.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 7.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 3.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 5.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 2.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336849
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap InterestAndOtherIncome Interest and Other Income USD 11.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 3.23M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap Liabilities Liabilities USD 27.67M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 500.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap LiabilitiesCurrent Liabilities, Current USD 25.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 319.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 189.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -25.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -77.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -123.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -123.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OperatingExpenses Operating Expenses USD 134.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -134.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 787,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 2.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OperatingLeasePayments Operating Lease, Payments USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 559,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OtherAssetsCurrent Other Assets, Current USD 2.48M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 247,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -2.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 54,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -2.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 6.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 536,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 237.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 11.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 688.80M 2026-02-04 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 63.50M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268148
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 215.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 7.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 254,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -123.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 5.95M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap RedeemableNoncontrollingInterestEquityPreferredCarryingAmount Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-039838
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 81.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap RestrictedCash Restricted Cash USD 205,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -347.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap SecurityDeposit Security Deposit USD 42,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 41.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 39.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.9 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-07 0000950170-25-104619
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.178 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.043 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.046 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.037 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 116.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.45M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 11.23 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 28.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 585,593 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 37.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 184.88M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 22.34 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 184.88M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 5.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 22.34 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 6.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 8.1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 39.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 21.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 44.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 472.95M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.083 2024-09-06 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 869,222 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 254,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 85.02M 2026-01-01 2026-03-31 2026 Q2 10-Q 2026-08-06 0001193125-26-336849
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.43M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 19,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2024-09-16 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2024-09-16 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 6.73M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 2.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 141,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 26.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-103121
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 47.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 47.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453583

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →